SCHEMBL8599519

SCHEMBL8599519

O=P([O-])([O-])C(N(CCN(C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])P(=O)([O-])[O-].O=P([O-])([O-])C(N(CCN(C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])P(=O)([O-])[O-].O=P([O-])([O-])C(N(CCN(C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])C(P(=O)([O-])[O-])P(=O)([O-])[O-])P(=O)([O-])[O-].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3].[Sm+3]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL3284821 0.94
Potassium Ion SCHEMBL3178660 0.94 SLC34A1 (0.30)
SCHEMBL8671681 0.94
SCHEMBL8599516 0.94
SCHEMBL1531298 0.94
SCHEMBL8763835 0.94
SCHEMBL3986401 0.94
SCHEMBL10535754 0.92
SCHEMBL8643089 0.92
SCHEMBL583191 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5762907-A RADIONUCLIDE COMPLEXED WITH A LIGAND THE DOW CHEMICAL COMPANY (US) 1998-06-09 US claimed
EP-0462787-A1 Radiopharmaceutical formulations, their method of administration and process of preparation THE DOW CHEMICAL COMPANY (US) 1991-12-27 EP claimed
JP-4230224-A None JP disclosed
US-5762907-A RADIONUCLIDE COMPLEXED WITH A LIGAND THE DOW CHEMICAL COMPANY (US) 1998-06-09 US disclosed
US-5762907-A RADIONUCLIDE COMPLEXED WITH A LIGAND THE DOW CHEMICAL COMPANY (US) 1998-06-09 US disclosed
CN-1033143-C Radiopharmaceutical formulations, their method of administration and process of preparation DOW CHEMICAL CO (US) 1996-10-30 CN disclosed
EP-0462787-B1 Radiopharmaceutical formulations, their method of administration and process of preparation DOW CHEMICAL CO (US) 1995-06-21 EP disclosed
JP-H04230224-A RADIOACTIVE PHARMACEUTICAL PREPARATION AND ITS PRODUCTION AND APPLICATION DOW CHEM CO:THE 1992-08-19 JP disclosed
EP-0462787-A1 Radiopharmaceutical formulations, their method of administration and process of preparation THE DOW CHEMICAL COMPANY (US) 1991-12-27 EP disclosed
EP-0462787-A1 Radiopharmaceutical formulations, their method of administration and process of preparation THE DOW CHEMICAL COMPANY (US) 1991-12-27 EP disclosed